Table 5. Detection of rifampicin resistance by Xpert according to MDR-TB prevalence.
| MDR-TB prevalence | Country | MTB+/RIF resistant | MTB+/RIF susceptible | MTB+/RIF indeterminate | TOTAL MTB+ |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n | ||
| Colombia | 23 (11.1) | 184 (88.9) | 0 (0.0) | 207 | |
| Georgia | 30 (18.4) | 130 (79.8) | 3 (1.8) | 163 | |
| India | 5 (35.7) | 9 (64.3) | 0 (0.0) | 14 | |
| Kyrgyzstan | 137 (36.0) | 237 (62.2) | 7 (1.8) | 381 | |
| Lesotho | 13 (7.6) | 158 (92.4) | 0 (0.0) | 171 | |
| High | Myanmar | 71 (16.9) | 339 (80.9) | 9 (2.1) | 419 |
| Russia | 80 (25.4) | 234 (74.3) | 1 (0.3) | 315 | |
| South Africa | 235 (13.9) | 1,451 (86.0) | 2 (0.1) | 1,688 | |
| Swaziland | 197 (10.5) | 1,636 (87.3) | 42 (2.2) | 1,875 | |
| Uzbekistan | 108 (41.4) | 147 (56.3) | 6 (2.3) | 261 | |
| SUBTOTAL | 899 (16.3) | 4,525 (82.3) | 70 (1.3) | 5,494 | |
| DRC | 17 (11.8) | 122 (84.7) | 5 (3.5) | 144 | |
| Cambodia | 21 (5.5) | 355 (92.7) | 7 (1.8) | 383 | |
| Kenya | 59 (5.3) | 1,031 (93.1) | 18 (1.6) | 1,108 | |
| Low | Malawi | 0 (0.0) | 49 (98.0) | 1 (2.0) | 50 |
| Mozambique | 99 (7.8) | 1,163 (91.6) | 7 (0.6) | 1,269 | |
| Zimbabwe | 73 (4.9) | 1,393 (94.1) | 15 (1.0) | 1,481 | |
| SUBTOTAL | 269 (6.1) | 4,113 (92.7) | 53 (1.2) | 4,435 | |
| TOTAL | 1,168 (11.7) | 8,638 (86.9) | 123 (1.2) | 9,929 |